Skip to main content
Clinical Trials/NCT02182817
NCT02182817
Unknown
N/A

Prospective Cohort Study of Effects of Exposure to General Anaesthesia in Infancy on Neurocognitive Development

KK Women's and Children's Hospital2 sites in 1 country250 target enrollmentNovember 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
Central Nervous System Complications of Anesthesia
Sponsor
KK Women's and Children's Hospital
Enrollment
250
Locations
2
Primary Endpoint
Neurocognitive Assessment: Bayley's Scale of Infant Development-III
Last Updated
5 years ago

Overview

Brief Summary

This prospective cohort study aims to determine if apparently healthy children with no significant co-morbidities who undergo general anaesthesia for minor surgery before 15 months of age will develop measurable deficits in neurocognitive development compared to apparently healthy children with no significant co-morbidities who do not undergo general anaesthesia or surgery.

Detailed Description

We hypothesize that healthy children exposed to general anaesthesia for minor surgery before 15 months of age will have significantly lower neurocognitive scores at 6,18, 24 and 36 months of age compared with age, and gender matched healthy children from the GUSTO cohort without prior exposure to general anaesthesia or surgery. (GUSTO: Growing Up Towards Healthy Outcomes in Singapore: a prospective longitudinal study providing normative data from the local population).

Registry
clinicaltrials.gov
Start Date
November 2013
End Date
December 2021
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
KK Women's and Children's Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Infants born \> 36 weeks gestation
  • No significant co-morbidities
  • Who undergo general sevoflurane anaesthesia for minor surgery lasting \<150 minutes (including herniotomies, orchidopexies, circumcisions and pyloromyotomies) before 15 months of age

Exclusion Criteria

  • Prematurity \<36 weeks gestation
  • Birth weight less than 2400g
  • Presence of a genetic or chromosomal disorder
  • Disorder of the central nervous system, including any seizure disorder
  • Major congenital cardiac defects

Outcomes

Primary Outcomes

Neurocognitive Assessment: Bayley's Scale of Infant Development-III

Time Frame: 24 months of age

Bayley's Scale of Infant Development-III

Secondary Outcomes

  • Neurocognitive Assessment: Habituation(6 and 18 months of age)
  • Visual Expectation(6 and 18 months of age)
  • Event Related Potential(6 and 18 months of age)
  • Neurocognitive Assessment: Deferred Imitation(6 and 18 months of age)
  • Behavioural Assessment: Child behaviour checklist(24 months of age)

Study Sites (2)

Loading locations...

Similar Trials